Dr. Ashley L. Sturgeon, MD

Dr. Sturgeon practices at Dermatology Associates of West Texas in Lubbock, Texas.

Dr. Sturgeon's NPI, 1285955492, was assigned on June 22, 2010. Dr. Sturgeon graduated from Texas Tech University Health Sciences Center School of Medicine in 2010. Dr. Sturgeon's Texas license number on file is P7991.

Dr. Sturgeon's primary practice is Dermatology Associates of West Texas, at 2202 Ithaca Ave, Lubbock, TX 79410 in Lubbock County. The practice phone is (806) 797-1202.

Dr. Sturgeon's primary practice is Dermatology Associates of West Texas in Lubbock, Texas. Dr. Sturgeon is also affiliated with University Medical Center. The medical group on file is Dermatology Associates of West Texas. Dmand AI also links Dr. Sturgeon to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sturgeon practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sturgeon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sturgeon is board certified in dermatology by the American Board of Dermatology. Dr. Sturgeon has a license on file in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and psoriasis among the conditions Dr. Sturgeon treats.

CMS data shows 5,501 Medicare services from Dr. Sturgeon across 28 procedure codes in 2024, for 761 Medicare patients. Medicare paid $316,790 for them. Every service was in an office.

CMS counts 761 Medicare patients who saw Dr. Sturgeon in 2024. The largest group is 65 to 74, with 437 patients. 71% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sturgeon's median patient age at 67, with 63% women.

In 2024, Dr. Sturgeon wrote 1,092 Medicare Part D claims for 420 patients. 94% of them were for generic drugs. CMS names the drug for 949 of them, across 21 drugs with 11 or more claims each, at $136,383 in total drug cost. In 2023, CMS named 792 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Sturgeon for performance year 2024, reported individually. Dr. Sturgeon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,345 procedures of removal of skin lesions by Dr. Sturgeon, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Sturgeon, published from 2015 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Dermatology and Medically Uninsured. Dr. Sturgeon has published most often in Proc (Bayl Univ Med Cent). Dr. Sturgeon's most frequent co-authors are Michelle Babb Tarbox, MD, Cloyce L. Stetson, MD and Usman Asad, MD.

CMS Open Payments shows 629 general payments to Dr. Sturgeon from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $4,840.

Dmand AI lists 1 award for Dr. Sturgeon, most recently C. Frank Webber, MD Award for Outstanding Service to the TMA Medical Student Section in 2021.

Dr. Sturgeon graduated from Texas Tech University Health Sciences Center School of Medicine in 2010.

Dr. Sturgeon is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.